CRGX Insider Trading

Insider Ownership Percentage: 1.38%
Insider Buying (Last 12 Months): $4,998,000.00
Insider Selling (Last 12 Months): $114,912.25

CARGO Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at CARGO Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CARGO Therapeutics Share Price & Price History

Current Price: $16.23
Price Change: Price Increase of +0.5 (3.18%)
As of 11/22/2024 01:00 AM ET

This chart shows the closing price history over time for CRGX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

CARGO Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/19/2024Gina ChapmanCEOSell2,975$25.03$74,464.25103,905View SEC Filing Icon  
9/18/2024Anup RadhakrishnanCFOSell1,600$25.28$40,448.006,446View SEC Filing Icon  
5/30/2024Samsara Biocapital Gp, LlcMajor ShareholderBuy294,000$17.00$4,998,000.004,415,689View SEC Filing Icon  
11/14/2023Perceptive Advisors LlcMajor ShareholderBuy666,666$15.00$9,999,990.002,912,835View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for CARGO Therapeutics (NASDAQ:CRGX)

93.16% of CARGO Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CRGX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

CARGO Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC56,354$1.04M0.0%+226.7%0.122%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC838,279$15.47M0.0%+80.6%1.821%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC56,354$1.04M0.0%+226.7%0.122%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC15,707$0.29M0.0%-73.8%0.034%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP2,042,723$37.69M0.0%+4.1%4.438%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.190,506$3.52M0.6%+22.5%0.414%Search for SEC Filing on Google Icon
11/15/2024State Street Corp839,861$15.50M0.0%+11.7%1.825%Search for SEC Filing on Google Icon
11/15/2024RTW Investments LP4,098,955$75.63M1.1%+0.5%8.905%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC2,675,285$49.34M0.0%+1.8%5.812%Search for SEC Filing on Google Icon
11/14/2024Sio Capital Management LLC173,860$3.21M1.3%N/A0.379%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC11,262$0.21M0.0%-13.6%0.025%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC19,833$0.37M0.0%+59.3%0.043%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets11,438$0.21M0.0%+437.8%0.025%Search for SEC Filing on Google Icon
11/13/2024FMR LLC6,954,476$128.31M0.0%+1.1%15.151%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 136,151$2.51M0.0%-14.4%0.297%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.295,960$5.46M0.0%+87.7%0.645%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC12,679$0.23M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/20/2024Novo Holdings A S1,544,000$25.35M1.3%+23.5%3.367%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC3,683,004$60.48M1.4%+6.8%8.031%Search for SEC Filing on Google Icon
8/15/2024CVI Holdings LLC70,000$1.15M1.0%N/A0.153%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company159,019$2.61M0.0%+20.3%0.347%Search for SEC Filing on Google Icon
8/14/2024Yu Fan912,000$14.98M19.6%N/A1.989%Search for SEC Filing on Google Icon
8/7/2024Cowen AND Company LLC554,305$9.10M0.3%+121.7%1.209%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc289,352$4.75M0.0%+78.7%0.631%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers30,639$0.50M0.0%+14.0%0.067%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp69,171$1.14M0.0%+11.5%0.151%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System15,115$0.34M0.0%N/A0.038%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC2,659,580$59.29M0.0%-1.6%6.755%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD3,093,347$69.04M0.0%+38.2%7.857%Search for SEC Filing on Google Icon
5/14/2024StemPoint Capital LP51,126$1.14M0.3%+90.2%0.130%Search for SEC Filing on Google Icon
5/14/2024American International Group Inc.10,597$0.24M0.0%N/A0.027%Search for SEC Filing on Google Icon
5/13/2024Ameritas Investment Partners Inc.2,144$48K0.0%N/A0.005%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,116,293$24.92M0.0%+179.5%2.835%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank28,500$0.64M0.0%N/A0.072%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets10,664$0.24M0.0%N/A0.027%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP1,711,502$39.01M0.0%N/A4.154%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC3,436,600$79.56M1.8%N/A8.339%Search for SEC Filing on Google Icon
2/14/2024RTW Investments LP5,175,832$119.82M1.9%N/A12.560%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.575,920$13.33M0.0%N/A1.398%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
CARGO Therapeutics logo
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.
Read More on CARGO Therapeutics

Today's Range

Now: $16.23
Low: $15.50
High: $16.73

50 Day Range

MA: $19.99
Low: $15.73
High: $25.00

52 Week Range

Now: $16.23
Low: $13.56
High: $33.92

Volume

163,387 shs

Average Volume

196,359 shs

Market Capitalization

$747.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of CARGO Therapeutics?

CARGO Therapeutics' top insider investors include:
  1. Samsara Biocapital Gp, Llc (Major Shareholder)
  2. Perceptive Advisors Llc (Major Shareholder)
  3. Gina Chapman (CEO)
  4. Anup Radhakrishnan (CFO)
Learn More about top insider investors at CARGO Therapeutics.

Who are the major institutional investors of CARGO Therapeutics?

CARGO Therapeutics' top institutional shareholders include:
  1. FMR LLC — 15.15%
  2. RTW Investments LP — 8.90%
  3. Janus Henderson Group PLC — 5.81%
  4. Wellington Management Group LLP — 4.44%
  5. State Street Corp — 1.82%
  6. Geode Capital Management LLC — 1.82%
Learn More about top institutional investors of CARGO Therapeutics stock.

Which major investors are selling CARGO Therapeutics stock?

During the previous quarter, CRGX stock was sold by these institutional investors:
  1. Jane Street Group LLC
  2. The Manufacturers Life Insurance Company
  3. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
In the last year, company insiders that have sold CARGO Therapeutics company stock include:
  1. Samsara Biocapital Gp, Llc (Major Shareholder)
  2. Perceptive Advisors Llc (Major Shareholder)
Learn More investors selling CARGO Therapeutics stock.

Which major investors are buying CARGO Therapeutics stock?

In the last quarter, CRGX stock was bought by institutional investors including:
  1. Geode Capital Management LLC
  2. Sio Capital Management LLC
  3. Charles Schwab Investment Management Inc.
  4. State Street Corp
  5. Wellington Management Group LLP
  6. FMR LLC
  7. Janus Henderson Group PLC
  8. Barclays PLC
In the previous year, these company insiders have bought CARGO Therapeutics stock:
  1. Samsara Biocapital Gp, Llc (Major Shareholder)
  2. Perceptive Advisors Llc (Major Shareholder)
Learn More investors buying CARGO Therapeutics stock.